fda changes semaglutide Live Updates on Semaglutide's Current and Future Uses FDA Warns on Certain Forms

Written By: Joseph Shavit/Edited By: Joshua Shavit A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world's hardest to quit addictions

[DOI] [PMC free article] [PubMed] [Google Scholar] 235.De Marinis, Y

The SURPASS trials demonstrated tirzepatide's superiority in both weight loss and blood sugar control for people with type 2 diabetes

Personal stories vary: one person described needing new glasses because cheekbones showed more

[3] Encourages better long-term outcomes, making it easier to keep weight off after the medication ends

Low Blood Sugar (Hypoglycemia): While semaglutide rarely causes low blood sugar on its own, the risk increases if you take it alongside insulin or sulfonylureas